Call for Abstract

4th International Congress on Addictive Behavior and Dual Diagnosis, will be organized around the theme “Exploring Advance Methodologies for Addiction & Mental Disorders Treatment”

dual-diagnosis-2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in dual-diagnosis-2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1NSAIDS Addiction
  • Track 1-2Psychodynamic therapy
  • Track 1-3Cognitive impairment
  • Track 1-4Durg use and toxicity
  • Track 1-5Drug addiction recovery
  • Track 1-6Drug addiction diagnosis
  • Track 1-7Tobacco abuse
  • Track 1-8Hallucinogens Abuse
  • Track 1-9Cocaine addiction
  • Track 1-10Post-traumatic stress disorder
  • Track 2-1Marijuana addiction
  • Track 2-2Pharmacotherapies
  • Track 2-3Pain management
  • Track 2-4alcoholism and brain
  • Track 2-5Addiction and brain disorders
  • Track 2-6Autism spectrum disorder
  • Track 2-7Alcohol detoxification using chemotherapeutic agents
  • Track 2-8Schizophrenia
  • Track 2-9Psychosis
  • Track 2-10Alcoholism
  • Track 2-11Alcoholic dementia
  • Track 3-1Philosophical and ethical themes in mental health
  • Track 3-2Mental health across the life span
  • Track 3-3Mental health in developing regions
  • Track 3-4Mental health services and policies
  • Track 4-1NSAIDS and Mental illness
  • Track 4-2Neurogenetics of Substance Related Disorders
  • Track 4-3Alcoholic Liver Disease
  • Track 4-4Lung Health and Immunity
  • Track 4-5Adaptive Immune System
  • Track 4-6Alcohol and Viral Hepatitis
  • Track 4-7HIV/AIDS
  • Track 4-8Drug induced disorders
  • Track 4-9Drug Abuse and Mental Health
  • Track 4-10Drug dependence
  • Track 4-11Drug addiction in Children and Adolescents
  • Track 4-12Mental health and symptoms
  • Track 5-1Borderline personality therapy
  • Track 5-2Integrated treatment for dual disorders
  • Track 5-3Nicotine replacement therapy
  • Track 5-4Cognitive behavioral therapy
  • Track 5-5Multidimensional family therapy
  • Track 5-6Psychodynamic therapy
  • Track 5-7Dialectical behavioral therapy
  • Track 5-8Prenatal Alcohol Exposure
  • Track 6-1Marijuana use
  • Track 6-2Opioid dependence
  • Track 6-3Opioid treatment
  • Track 6-4Advances in addiction psychology
  • Track 6-5Anxiety, Depression and Insomnia
  • Track 6-6Attention-deficit hyperactivity disorder
  • Track 6-7Obsessive-Compulsive Disorder
  • Track 7-1Addiction & Toxicology
  • Track 7-2Alcohol detoxification using chemotherapeutic agents
  • Track 7-3Alcohol detoxification using chemotherapeutic agents
  • Track 7-4Alcoholic Liver Disease
  • Track 7-5Lung Health and Immunity
  • Track 8-1Post-traumatic stress disorder
  • Track 8-2Alcoholism- Amnesia, anxiety, depression
  • Track 8-3Surgical addiction
  • Track 8-4Food addiction
  • Track 8-5Internet Addiction
  • Track 8-6Gambling Addiction
  • Track 8-7Sexual Addiction
  • Track 8-8Behavioral addiction
  • Track 8-9Antisocial Personality Disorder
  • Track 8-10Emergency Mental health
  • Track 8-11Amphetamines- schizophrenia
  • Track 9-1Drug dependence
  • Track 9-2Drug Abuse and Mental Health
  • Track 9-3Drug induced disorders
  • Track 9-4HIV/AIDS
  • Track 9-5Alcohol and Viral Hepatitis
  • Track 9-6NSAIDS and Mental illness
  • Track 9-7Drug addiction in Children and Adolescents
  • Track 10-1Personality disorder
  • Track 10-2Anxiety disorders
  • Track 10-3Diagnosing bipolar test
  • Track 10-4Manic bipolar disorder
  • Track 10-5Bipolar schizophrenia
  • Track 10-6Advanced therapeutics in Bipolar treatment
  • Track 10-7Bipolar Psychiatrists
  • Track 11-1Clinical Depression
  • Track 11-2Major Depression
  • Track 11-3Advanced Depression
  • Track 11-4Severe Depression
  • Track 11-5Advances in Depression test
  • Track 11-6Advances in clinical depression disorders
  • Track 11-7Obsessive Compulsive Disorder
  • Track 12-1Cannabis - hallucinations and delusions
  • Track 12-2Molecular Biology and Genetics
  • Track 12-3Substance abuse disorders
  • Track 12-4Advances in Neurotoxicology
  • Track 12-5Benzodiazepine - Sedation & Hypnotism
  • Track 12-6Ketamine - Antisocial personality disorders
  • Track 12-7Opioids - Insomnia
  • Track 12-8Marijuana - Schizophrenia
  • Track 12-9Cocaine - Dementia
  • Track 12-10Smoking
  • Track 13-1Drug receptors
  • Track 13-2Drugs and their effects on addiction
  • Track 13-3Drug tolerance
  • Track 13-4Drug dependence
  • Track 13-5Drug Addiction and Consequences
  • Track 14-1Detoxification stage
  • Track 14-2Relapse and Management
  • Track 14-3Alcohol Facts
  • Track 14-4Trans cranial Magnetic Stimulation
  • Track 14-5Psychotropic substance abusers
  • Track 14-6Residential Drug Rehabilitation Program
  • Track 15-1Mental Health
  • Track 15-2Dialectical behavioral therapy
  • Track 15-3Psychodynamic therapy
  • Track 15-4Residential treatment
  • Track 15-5Contingency management
  • Track 15-6Motivational interviewing
  • Track 15-7Psychology and Education
  • Track 15-8Spiritual sciences
  • Track 15-9Behavioral health sciences
  • Track 15-10Emotional health
  • Track 15-11Cognitive impairment
  • Track 16-1Neurodegenerative Disorder
  • Track 16-2Holistic and Alternative Treatment Approaches
  • Track 16-3Mindfulness
  • Track 16-4Addictive Brain Disorder and Neurosurgery